|
DMTF1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.23829999995906E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.571400E-04 |
| Normal-vs-Stage2 |
8.31390000000098E-05 |
| Normal-vs-Stage3 |
1.10660000052221E-08 |
| Normal-vs-Stage4 |
1.822870E-03 |
| Stage1-vs-Stage2 |
2.335000E-01 |
| Stage1-vs-Stage3 |
6.502800E-03 |
| Stage1-vs-Stage4 |
4.872000E-01 |
| Stage2-vs-Stage3 |
4.385800E-01 |
| Stage2-vs-Stage4 |
7.964200E-01 |
| Stage3-vs-Stage4 |
3.601800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.79059999999765E-06 |
| Normal-vs-AfricanAmerican |
1.035790E-02 |
| Normal-vs-Asian |
1.437640E-01 |
| Caucasian-vs-AfricanAmerican |
6.765800E-01 |
| Caucasian-vs-Asian |
1.494320E-02 |
| AfricanAmerican-vs-Asian |
2.404600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.597200E-04 |
| Normal-vs-Female |
2.0281999999483E-06 |
| Male-vs-Female |
4.954200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.767500E-04 |
| Normal-vs-Age(41-60Yrs) |
5.77889999999748E-05 |
| Normal-vs-Age(61-80Yrs) |
2.58399999997216E-06 |
| Normal-vs-Age(81-100Yrs) |
9.177500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.283000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.846250E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.393970E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.868440E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.565500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.205400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.79999999996949E-06 |
| Classical-VS-Follicular |
8.624800E-01 |
| Classical-VS-Other |
3.031800E-01 |
| Classical-VS-Normal |
6.202700000002E-05 |
| Tall-VS-Follicular |
1.120600E-03 |
| Tall-VS-Other |
8.515500E-02 |
| Tall-VS-Normal |
1.50319978686753E-10 |
| Follicular-VS-Other |
3.999200E-01 |
| Follicular-VS-Normal |
1.138460E-03 |
| Other-VS-Normal |
5.590800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.43400000055472E-07 |
| Normal-vs-N1 |
1.008040E-01 |
| N0-vs-N1 |
1.127830E-01 |
|
|
